| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $24K | +123.7% |
| R&D Expense | $440K | -5.1% |
| SG&A Expense | $377K | +54.2% |
| Operating Income | -$2.3M | +13.1% |
| Net Income | -$2.6M | +1.3% |
| EPS (Basic) | $0.00 | — |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Current Assets | $86K | -72.5% |
| Total Assets | $289K | -47.4% |
| Current Liabilities | $1.8M | +19.4% |
| Total Liabilities | $1.8M | +17.9% |
| Stockholders' Equity | -$1.5M | -55.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.7M | +9.0% |
| Capital Expenditures | $12K | +0.0% |
| Investing Cash Flow | $20K | +407.7% |
| Financing Cash Flow | $1.6M | +8.9% |
| Free Cash Flow | -$1.7M | +9.0% |